STOCK TITAN

VIR affiliate files Rule 144 notice; insider sales listed (NASDAQ: VIR)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

VIR filed a Rule 144 notice reporting proposed sales of common stock. The filing lists an exercise of stock options and a sale quantity of 20,377 shares on 02/24/2026 for cash. It also lists prior 10b5-1 sales by Vicki Lee Sato of 22,000 shares on 02/02/2026 for $169,670.60, 22,000 shares on 01/02/2026 for $130,383.00, and 22,000 shares on 12/01/2025 for $132,070.40.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does VIR's Form 144 disclose?

It discloses a proposed sale of common stock following an option exercise and prior Rule 10b5-1 transactions. The filing lists 20,377 shares from an exercise on 02/24/2026 and three prior 10b5-1 sales of 22,000 shares each.

Who executed prior 10b5-1 sales reported in the filing?

The prior 10b5-1 sales were executed by Vicki Lee Sato. The filing shows sales of 22,000 shares on 12/01/2025, 01/02/2026, and 02/02/2026 with listed proceeds for each trade.

What proceeds are listed for the recent 10b5-1 trades?

The filing lists proceeds of $169,670.60 for 02/02/2026, $130,383.00 for 01/02/2026, and $132,070.40 for 12/01/2025. These amounts are the reported gross proceeds for each block of 22,000 shares.

Does the Form 144 indicate the sale method or cash treatment?

Yes; the filing states the 02/24/2026 transaction arises from an exercise of stock options and is for cash. Additional plan or distribution mechanics are not detailed in the excerpt.
Vir Biotechnology, Inc.

NASDAQ:VIR

View VIR Stock Overview

VIR Rankings

VIR Latest News

VIR Latest SEC Filings

VIR Stock Data

1.34B
126.52M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SAN FRANCISCO